{
    "id": "0248",
    "question": "A 49-year-old woman comes to the physician for a scheduled colposcopy. Two weeks ago, she had a routine Pap smear that showed atypical squamous cells. Colposcopy shows an area of white discoloration of the cervix with application of acetic acid solution. Biopsy of this area shows carcinoma-in-situ. Activation of which of the following best explains the pathogenesis of this condition?",
    "options": {
        "A": "JAK2 tyrosine kinase",
        "B": "E2F transcription factors",
        "C": "Phosphoprotein p53",
        "D": "Cyclin-dependent kinase inhibitors"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To solve this question, we need to understand the relationship between the given clinical scenario and the molecular mechanisms of cervical carcinogenesis. The patient has a history of atypical squamous cells on a Pap smear, which led to a colposcopy and a biopsy showing carcinoma-in-situ. Carcinoma-in-situ is a precancerous condition where cells have the potential to progress to invasive cancer. The key to answering this question lies in understanding the molecular pathways involved in cervical carcinogenesis. The Epstein-Barr virus (EBV) and human papillomavirus (HPV) are known to play a significant role in cervical carcinogenesis. HPV is a common cause of cervical cancer, and its integration into the host genome can lead to the disruption of normal cell cycle regulation. The E6 and E7 proteins of HPV can inactivate the tumor suppressor proteins p53 and Rb, respectively, leading to uncontrolled cell proliferation. Among the options provided, the activation of phosphoprotein p53 is a direct consequence of HPV infection, as p53 is a critical tumor suppressor that regulates the cell cycle and prevents cancer formation. The E6 protein of HPV can bind to p53, leading to its degradation and inactivation. Therefore, the activation of phosphoprotein p53 is the most likely explanation for the pathogenesis of carcinoma-in-situ in this patient.\", \"answer_choice\": \"C\"}",
    "snippets": [
        {
            "id": "Gynecology_Novak_3015",
            "title": "Gynecology_Novak",
            "content": "High-Grade Squamous Any woman with a cytologic specimen suggesting the presence of HSIL should undergo Intraepithelial Lesions colposcopy and directed biopsy (75). This is because two-thirds of patients with this cytologic finding will have CIN 2 or greater. After colposcopically directed biopsy and determination of the distribution of the lesion, excisional or ablative therapy that addresses the entire transformation zone should be performed. Acetowhite Epithelium Epithelium that turns white after application of acetic acid (3%\u2013 5%) is called acetowhite epithelium (53). The application of acetic acid coagulates the proteins of the nucleus and cytoplasm and makes the proteins opaque and white (5)."
        },
        {
            "id": "Surgery_Schwartz_11854",
            "title": "Surgery_Schwartz",
            "content": "and direct resection of the lesion with scissors or cervi-cal biopsy instrument (Schubert, Kevorkian, etc) can achieve an adequate biopsy.Colposcopy and Cervical Biopsy. In cases of an abnormal Pap smear cytology or positive HPV testing, a colposcopy is performed for a histologic evaluation. A colposcope is used to achieve 2x to 15x magnification of the cervix. Once the cer-vix is visualized, cervical mucus, if present, is removed, and then 3% acetic acid is applied to the cervix for one minute. This application dehydrates cells and causes dysplastic cells with dense nuclei to appear white. The lining of the cervix consists of squamous epithelium on the ectocervix, whereas columnar epithelium lines the endocervical canal. The ectocervix there-fore appears smooth and pale pink in color while the endocervix forms epithelial fronds or \u201cgrape-like\u201d structures visible through the colposcope. The junction between columnar and squamous cell types is called the squamocolumnar junction (SCJ),"
        },
        {
            "id": "Pathology_Robbins_4291",
            "title": "Pathology_Robbins",
            "content": "Fig.19.6). (Courtesy of Dr. Edmund S. Cibas, Brigham and Women\u2019s Hospital, Boston, Massachusetts.) http://ebooksmedicine.net SIL is asymptomatic and comes to clinical attention through an abnormal Pap smear result. These cases are followed up by colposcopy, in which acetic acid is used to highlight the lesions so they can be biopsied. Women with biopsy-documented LSIL are managed conservatively with careful observation, whereas HSILs and persistent LSIL are treated with surgical excision (cone biopsy). Follow-up smears and clinical examination are required in patients with HSIL, as these women remain at risk for HPV-associated cervical, vulvar, and vaginal cancers."
        },
        {
            "id": "Gynecology_Novak_3022",
            "title": "Gynecology_Novak",
            "content": "Correlation of Findings Ideally, both the pathologist and colposcopist should review the colposcopic findings and the results of cytologic assessment, cervical biopsy, and endocervical sample before deciding therapy. This is particularly valuable when operators are learning the technique of colposcopy. Cytology results should not be sent to one laboratory and the histology results to another. When the cytology and biopsy results correlate, the colposcopist can be reasonably certain that the worst lesion was identified. If the cytology indicates a more significant lesion than the histology, the patient may require further evaluation, including repeat colposcopy, additional biopsies, and excisional diagnostic procedures under certain circumstances. An algorithm for the evaluation, treatment, and follow-up of abnormal Pap test results is presented in Figure 19.14. CHAPTER 19 Intraepithelial Disease of the Cervix, Vagina, and Vulva"
        },
        {
            "id": "Gynecology_Novak_7083",
            "title": "Gynecology_Novak",
            "content": "In early squamous cell lesions, the diagnosis is often suggested by an abnormal Pap test result; however, this is not true for clear cell adenocarcinomas, which are characterized by submucosal growth. In these cases, the diagnosis is suggested by cytologic findings in only 33% of cases. Visually suspicious areas in the vagina should be evaluated with a targeted biopsy using the same instruments as those used for cervical biopsies. Careful palpation of the vagina may be helpful in detecting submucosal irregularities. The most common site of vaginal cancer is in the upper one-third of the vagina on the posterior wall. The developing tumor may be missed during initial inspection because of obscured visualization caused by the blades of the speculum (214). Colposcopy is valuable in evaluating patients with abnormal Pap test results, unexplained vaginal bleeding, or ulcerated erythematous patches in the upper vagina. A colposcopically targeted biopsy may not allow a definitive diagnosis,"
        },
        {
            "id": "Gynecology_Novak_3035",
            "title": "Gynecology_Novak",
            "content": "2. If the HPV DNA test is negative or two consecutive Pap smears are reported as negative, return to routine screening is recommended. 3. If CIN 1 persists for 2 years or more, continued follow-up or treatment is appropriate. Treatment can be ablative or excisional. 4. If colposcopy is unsatisfactory or the endocervical sample is positive for a high-grade CIN, a diagnostic excisional procedure is recommended. 5. Two consecutive negative Pap tests in follow-up of low-grade lesions is not absolute indication that the disease regressed. 1. Women with a histologic diagnosis of CIN 1 diagnosed during the assessment of pap tests showing HSIL (CIN 2 or 3) or atypical glandular cells-not otherwise specified (AGC-NOS) can be managed by either an excisional diagnostic procedure or 6monthly colposcopy and cytology for 1 year (Fig 19.16B). Those with a cytological finding of AGC-NOS must have a satisfactory colposcopic examination and negative endocervical sampling. 2."
        },
        {
            "id": "Gynecology_Novak_3049",
            "title": "Gynecology_Novak",
            "content": "Conization Conization of the cervix plays an important role in the management of CIN. Before the availability of colposcopy, conization was the standard method of evaluating an abnormal Pap test result. Conization is both a diagnostic and therapeutic procedure and has the advantage over ablative therapies of providing tissue for further evaluation to rule out invasive cancer (117,118,120,124). Conization is indicated for diagnosis in women with HSIL or AGC-adenocarcinoma in situ and may be considered under the following conditions: 1. Limits of the lesion cannot be visualized with colposcopy. 2. The SCJ is not seen at colposcopy. 3. Endocervical curettage (ECC) histologic findings are positive for CIN 2 or CIN 3. 4. Substantial lack of correlation between cytology, biopsy, and colposcopy results. 5. Microinvasion is suspected based on biopsy, colposcopy, or cytology results. 6. The colposcopist is unable to rule out invasive cancer."
        },
        {
            "id": "Gynecology_Novak_3062",
            "title": "Gynecology_Novak",
            "content": "Screening Women with an intact cervix should undergo routine cytologic screening. Because VAIN is nearly always accompanied by CIN, the Pap test result is likely to be positive when VAIN is present. The vagina should be carefully inspected by colposcopic examination at the time of colposcopy for any CIN lesion. Particular attention should be paid to the upper vagina. Women who have persistent abnormal Pap tests without evident cervical pathology and those with abnormal cytology after treatment of CIN should be examined carefully for VAIN. For women in whom the cervix was removed for high-grade cervical neoplasia, Pap testing should be performed at regular intervals (e.g., yearly), depending on the diagnosis and severity of lesion. Figure 19.17 Human papillomavirus (HPV)/vaginal intraepithelial neoplasia grade 1 (VAIN 1). Note the surface spicules with partial uptake of Lugol\u2019s stain."
        },
        {
            "id": "First_Aid_Step2_853",
            "title": "First_Aid_Step2",
            "content": "Atypical glandular cells (AGC): < 35 years of age with no endometrial cancer risk factors: Proceed to colposcopy, endocervical curettage (ECC), and HPV DNA testing. \u2265 35 years of age, endometrial cancer factors, or abnormal bleeding: Add an endometrial biopsy. Atypical squamous cells of undetermined signif cance (ASC-US): \u2264 21 years of age: Repeat Pap smear at 12 months. If Pap smear is or reveals ASC-US or LSIL, repeat at 12 months. > 21 years of age: Immediate colposcopy, HPV DNA testing, and repeat Pap smear at 6 months. Low-grade squamous intraepithelial lesions (LSIL): \u2264 21 years of age: Same as ASC-US. > 21 years of age: Immediate colposcopy. High-grade squamous intraepithelial lesions (HSIL) or atypical squamous cells suspicious of high-grade dysplasia (ASC-H): Immediate colposcopy is indicated for all age groups. \u25a0Treatment is based on fndings of colposcopy: If colposcopy is satisfactory, proceed to treatment based on f ndings."
        },
        {
            "id": "Gynecology_Novak_3034",
            "title": "Gynecology_Novak",
            "content": "Ablative therapy is appropriate when the following conditions exist: 1. There is no evidence of microinvasive or invasive cancer on cytology, colposcopy, endocervical curettage, or biopsy. 2. The lesion is located on the ectocervix and can be seen entirely. 3. There is no involvement of the endocervix with high-grade dysplasia as determined by colposcopy and endocervical curettage. Management Summary This summary of the management of these histologic lesions is based on ASCCP 2006 Consensus Guidelines (adapted from MJ Campion [93]) (Fig 19.16): CIN 1 Preceded by ASC-US, ASC-H or LSIL Cytology 1. Women with a histologic diagnosis of CIN 1 preceded by ASC-US, ASC-H or LSIL cytology should be followed by yearly HPV-DNA testing or Pap tests every 6\u201312 months (Fig. 19.16A). If HPV DNA testing remains positive or if repeat cytology is reported as ASC-US or greater, repeat colposcopy is recommended. 2."
        },
        {
            "id": "Gynecology_Novak_3018",
            "title": "Gynecology_Novak",
            "content": "Leukoplakia should not be confused with the white plaque of a monilial infection, which can be completely wiped off with a cotton-tipped applicator. The most common reason for leukoplakia is HPV infection (Fig. 19.8). Because it is not possible to see through the thick keratin layer to the underlying vasculature during colposcopy, such areas should undergo biopsy to rule out keratinizing carcinoma. CHAPTER 19 Intraepithelial Disease of the Cervix, Vagina, and Vulva Figure 19.8 Colposcopy of cervical intraepithelial neoplasia 2 (CIN 2) associated with human papillomavirus (HPV) infection of the cervix."
        },
        {
            "id": "Gynecology_Novak_7041",
            "title": "Gynecology_Novak",
            "content": "The incidence of invasive cervical cancer associated with pregnancy is 1.2 in 10,000 (164). A Pap test should be performed on all pregnant patients at the initial prenatal visit, and any grossly suspicious lesions should be biopsied. Diagnosis is often delayed during pregnancy because bleeding is attributed to pregnancy-related complications. If the result of the Pap test is positive for malignant cells, and invasive cancer cannot be diagnosed using colposcopy and biopsy, a diagnostic conization procedure may be necessary. Conization in the first trimester of pregnancy is associated with hemorrhagic and infectious complications, and an abortion rate as high as 33% (165,166). Because conization subjects the mother and fetus to complications, it should not be performed before the second trimester and only in patients with colposcopy findings consistent with cancer, biopsy-proven microinvasive cervical cancer, or strong cytologic evidence of invasive cancer. Inadequate colposcopic"
        },
        {
            "id": "Surgery_Schwartz_11855",
            "title": "Surgery_Schwartz",
            "content": "the endocervix forms epithelial fronds or \u201cgrape-like\u201d structures visible through the colposcope. The junction between columnar and squamous cell types is called the squamocolumnar junction (SCJ), which in younger women is usually visible on the ectocervix. When columnar epithelium extends onto the ectocervix, it appears as a red zone surrounding the os and is called ectropion or ectopy. The transformation zone (TZ) is the area between mature squa-mous epithelium distally and columnar epithelium proximally, and it is the site of active squamous metaplasia. For colposcopy to be deemed adequate, the entire SCJ must be visualized dur-ing an adequate colposcopy. Areas with acetowhite, punctation, mosaicism, or atypical blood vessels seen during colposcopy may represent dysplasia or cancer and should be biopsied. A green filter enhances visualization of blood vessels by making them appear darker in contrast to the surrounding epithelium.An alternative to dilute acetic acid is Lugol\u2019s"
        },
        {
            "id": "Gynecology_Novak_3016",
            "title": "Gynecology_Novak",
            "content": "The acetic acid does not affect mature, glycogen-producing epithelium because the acid does not penetrate below the outer one-third of the epithelium. The cells in this region have very small nuclei and a large amount of glycogen (not protein). These areas appear pink during colposcopy. Dysplastic cells are those most affected. They contain large nuclei with abnormally large amounts of chromatin (protein). The columnar villi become \u201cplumper\u201d after acetic acid is applied, making these cells easier to see. They appear slightly white, particularly in the presence of the beginning signs of metaplasia. The immature metaplastic cells have larger nuclei and show some effects of the acetic acid. Because the metaplastic epithelium is very thin, it is not as white or opaque as CIN but instead appears gray and filmy (5)."
        },
        {
            "id": "First_Aid_Step2_854",
            "title": "First_Aid_Step2",
            "content": "\u25a0Treatment is based on fndings of colposcopy: If colposcopy is satisfactory, proceed to treatment based on f ndings. If colposcopy is unsatisfactory, perform ECC and cervical biopsy and proceed to treatment based on f ndings. Noninvasive disease: Treatment based on biopsy results for noninvasive lesions (stage 0 disease) is as follows (see Figure 2.12-7): CIN I: \u25a0Untreated CIN I will regress in 60% of patients, progress in 10%, and persist in 30%. Thus, the mainstay of treatment for CIN I is close observation. For women > 21 years of age, Pap smear screening at 6 and 12 months and/or HPV DNA testing at 12 months is indicated. For women \u2264 21 years of age, HPV testing is not recommended. After two Pap smears or a DNA test, patients can be managed with routine annual follow-up. Persistent CIN I can be treated with ablative (cryotherapy or laser ablation) or excisional therapy (loop electrosurgical excision procedure [LEEP]; laser and cold-knife conization)."
        },
        {
            "id": "Obstentrics_Williams_8625",
            "title": "Obstentrics_Williams",
            "content": "Accordingly, lesions suspicious for high-grade disease or cancer should undergo biopsy. Unsatisfactory colposcopic evaluation is less common during pregnancy because the transformation zone is better exposed due to cervical eversion. With insui cient visualization of the zone, colposcopy is repeated in 6 to 8 weeks. During this time, the squamocolumnar junction usually will further evert to permit satisfactory examination."
        },
        {
            "id": "Gynecology_Novak_7042",
            "title": "Gynecology_Novak",
            "content": "trimester and only in patients with colposcopy findings consistent with cancer, biopsy-proven microinvasive cervical cancer, or strong cytologic evidence of invasive cancer. Inadequate colposcopic examination may be encountered during pregnancy in patients who had prior ablative therapy. Close follow-up throughout pregnancy may allow the cervix to evert and develop an ectropion, allowing satisfactory colposcopy in the second or third trimester. Patients with obvious cervical carcinoma may undergo cervical biopsy and clinical staging similar to that of nonpregnant patients."
        },
        {
            "id": "InternalMed_Harrison_15346",
            "title": "InternalMed_Harrison",
            "content": "is included as an AIDS-defining condition. While only small increases in the absolute numbers of cervical or anal cancers have been seen as a consequence of HIV infection, the relative risk of these conditions when one compares HIV-infected to -noninfected men and women is on the order of 10to 100-fold. Given the high rates of dysplasia and relative risks for cervical and anal cancer, a comprehensive gynecologic and rectal examination, including Pap smear, is indicated at the initial evaluation and 6 months later for all patients with HIV infection. If these examinations are negative at both time points, the patient should be followed with yearly evaluations. If an initial or repeat Pap smear shows evidence of severe inflammation with reactive squamous changes, the next Pap smear should be performed at 3 months. If, at any time, a Pap smear shows evidence of squamous intraepithelial lesions, colposcopic examination with biopsies as indicated should be performed. The 2-year survival"
        },
        {
            "id": "Gynecology_Novak_3009",
            "title": "Gynecology_Novak",
            "content": "The option of repeat Pap testing is suboptimal because of a false-negative rate of 20% to 50% for identifying CIN lesions and practical issues with patient compliance. About 50% of patients will undergo colposcopy because of subsequent abnormal Pap test results, making this option nearly as costly as immediate colposcopy (69). Immediate colposcopy is assumed to be the most sensitive method of detecting CIN 2 or 3 (69,72). Because 80% of patients will not have significant lesions, it is important to avoid overinterpretation of the colposcopic findings and to be conservative in performing biopsies. There is the risk that pathologists will overinterpret the biopsy results and the patient will be diagnosed with CIN when metaplasia is the only finding."
        },
        {
            "id": "Gynecology_Novak_3024",
            "title": "Gynecology_Novak",
            "content": "women, and the management of adenocarcinoma in situ led to a critical review of the Guidelines (75,83). In 2006, the American Society for Colposcopy and Cervical Pathology (ASCCP) and the NCI sponsored a consensus conference to update evidence-based guidelines for abnormal cervical cancer screening. Comprehensive and specific guidelines for the management of cervical cytologic and histologic entities are available on the Web (84). The ASCCP 2006 Consensus Guidelines for management based on cytologic findings are presented in Figure 19.15 and those based on histologic findings are in Figure 19.16. Based on these recommendations, women with ASC-US should be managed initially with either (i) two repeat Pap tests with referral for colposcopy for any significant abnormality, (ii) immediate colposcopy, or (iii) testing for high-risk type HPV (Fig. 19.15A)."
        },
        {
            "id": "Surgery_Schwartz_11878",
            "title": "Surgery_Schwartz",
            "content": "(see earlier section, \u201cVulvar Condyloma\u201d).Vaginal Intraepithelial Neoplasia. Vaginal intraepithelial neoplasia, or VaIN, is similar to VIN and is classified based on the degree of epithelial involvement as mild (I), moderate (II), severe (III), or carcinoma in situ.26 Upwards of 65% to 80% of VaIN or vaginal cancers are associated with HPV infection. Typically, a patient will have a history of cervical dysplasia and a prior hysterectomy. The majority of lesions are located in the upper one-third of the vagina. Lesions are usually asymptomatic and found incidentally on cytological screening. Biopsy at the time of colposcopy is diagnostic and rules out invasive disease. VaIN is treated with laser ablation, surgical excision, or topical 5-FU therapy.4Brunicardi_Ch41_p1783-p1826.indd 179318/02/19 4:34 PM 1794SPECIFIC CONSIDERATIONSPART IICervical LesionsBenign Cervical Lesions. Benign lesions of the cervix include endocervical polyps, nabothian cysts (clear, fluid filled cysts with"
        },
        {
            "id": "Obstentrics_Williams_8631",
            "title": "Obstentrics_Williams",
            "content": "he incidence of invasive cervical carcinoma has dramatically declined in the United States as a result of PAP testing (American College of Obstetricians and Gynecologists, 2016b). This cancer is found in approximately 1 in 8500 pregnancies (Bigelow, 2017; Pettersson, 2010). The diagnosis is conirmed with biopsies taken during colposcopy, with conization, or from a grossly abnormal lesion. Of the histological types, squamous cell carcinomas account for 75 percent of all cervical cancers, whereas adenocarcinomas compose the remainder. Cancers may appear as exophytic or endophytic growth; as a polypoid mass, papillary tissue, or barrel-shaped cervix; or as focal ulceration or necrosis. A watery, purulent, foul, or bloody discharge may also be present. Biopsy with Tischler forceps is warranted for suspicious lesions. Abnormal tumor vessels may cause heavier than expected biopsy-site bleeding, which is usually controlled by Monsel paste and pressure."
        },
        {
            "id": "Gynecology_Novak_3040",
            "title": "Gynecology_Novak",
            "content": "2. Treatment is recommended for a histologic diagnosis of CIN 3 or if colposcopy is unsatisfactory. Although invasive cervical cancer is very rare in this age group, prospective follow-up of a histological diagnosis of CIN 2 or 3, not otherwise specified, in young women should be limited to those women likely to be compliant with the recommendations. 3. After 2 consecutive negative for intraepithelial lesion or malignancy results, implying negative cytology and colposcopy with satisfactory colposcopic examinations, adolescents and young women can return to routine cytologic screening. An annual screening interval should be recommended. 4. Treatment is recommended if CIN 3 is diagnosed histologically or if CIN 2 or 3 persists for 24 months. 1. Hysterectomy remains the preferred management recommendation for women with a histological diagnosis of AIS on a specimen from a diagnostic excisional procedure (Fig 19.16F). 2."
        },
        {
            "id": "InternalMed_Harrison_10822",
            "title": "InternalMed_Harrison",
            "content": "Cervical ectopy, often mislabeled \u201ccervical erosion,\u201d is easily confused with infectious endocervicitis. Ectopy represents the presence of the one-cell-thick columnar epithelium extending from the endocervix out onto the visible ectocervix. In ectopy, the cervical os may contain clear or slightly cloudy mucus but usually not yellow mucopus. Colposcopy shows intact epithelium. Normally found during adolescence and early adulthood, ectopy gradually recedes through the second and third decades of life, as squamous metaplasia replaces the ectopic columnar epithelium. Oral contraceptive use favors the persistence or reappearance of ectopy, while smoking apparently accelerates squamous metaplasia. Cauterization of ectopy is not warranted. Ectopy may render the cervix more susceptible to infection with N. gonorrhoeae, C. trachomatis, or HIV."
        },
        {
            "id": "Histology_Ross_4076",
            "title": "Histology_Ross",
            "content": "\u0081 FOLDER 23.6 Clinical Correlation: Cervix and Human Papillomavirus (HPV) Infections (Cont.) FIGURE F23.6.1 \u2022 Photomicrograph of in situ hybridization of a human cervical biopsy showing HPV infection. a. This low-magnification photomicrograph shows stratified squamous epithelium of the cervix hybridized with DNA probes to HPV types 6 and 11 and counterstained with nuclear fast red. Note that the majority of infected cells are mature cells located in the upper layers of the stratified squamous epithelium of the ectocervix. 120. b. This higher-magnification photomicrograph shows viral particles stained purple within the nuclei of infected cells. 225. (Courtesy of Dr. Fabiola Medeiros, Mayo Clinic.)"
        },
        {
            "id": "Gynecology_Novak_6914",
            "title": "Gynecology_Novak",
            "content": "Adenocarcinoma in situ (AIS) is believed to be the precursor of invasive adenocarcinoma, and it is not surprising that the two often coexist (32). In addition to AIS, intraepithelial or invasive squamous neoplasia occurs in 30% to 50% of cervical adenocarcinomas (33). A squamous intraepithelial lesion may be observed colposcopically on the ectocervix, and the coexistent adenocarcinoma often is higher in the cervical canal. Patients with AIS who are treated with conization should undergo close clinical follow-up."
        },
        {
            "id": "Pathoma_Husain_338",
            "title": "Pathoma_Husain",
            "content": "Progression from CIN to carcinoma, on average, takes 10-20 years. 2. Screening begins at age 21 and is initially performed every three years. B. Pap smear is the gold standard for screening. 1. Cells are scraped from the transformation zone using a brush and analyzed under a microscope. 2. Dysplastic cells are classified as low grade (CIN I) or high grade (CIN II and III). 3. High-grade dysplasia is characterized by cells with hyperchromatic (dark) nuclei and high nuclear to cytoplasmic ratios (Fig. 13.4C). C. Pap smear is the most successful screening test developed to date. Fig. 13.4 Cervix. A, Cervical transformation zone, normal. B, CIN Ill. C, High-grade dysplasia, Pap smear. (Courtesy of Ed Uthman, MD) 1. It is responsible for a significant reduction in the morbidity and mortality of cervical carcinoma (cervical carcinoma went from being the most common to one of the least common types of gynecologic carcinoma in the US). 2."
        },
        {
            "id": "Gynecology_Novak_3103",
            "title": "Gynecology_Novak",
            "content": "82. Wright YC Jr, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295\u2013304. 83. Wright TC, Massad LS, Dunton CJ, et al. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma-in-situ. Am J Obstet Gynecol 2007;197:340\u2013345. 84. (ASCCP) Consensus Guidelines. 2006. (www.asccp.org). 85. Guido R, Schiffman M, Solomon D, et al. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003;188:1401\u20131405. 86."
        },
        {
            "id": "Gynecology_Novak_3019",
            "title": "Gynecology_Novak",
            "content": "Figure 19.8 Colposcopy of cervical intraepithelial neoplasia 2 (CIN 2) associated with human papillomavirus (HPV) infection of the cervix. Punctation Dilated capillaries terminating on the surface appear from the ends as a collection of dots and are referred to as punctation (Fig. 19.9). When these vessels occur in a well-demarcated area of acetowhite epithelium, they indicate an abnormal epithelium\u2014 most often CIN (5) (Fig. 19.10). The punctate vessels are formed as the metaplastic epithelium migrates over the columnar villi. Normally, the capillary regresses; however, when CIN occurs, the capillary persists and appears more prominent. Figure 19.9 Diagram of punctation. The central capillaries of the columnar villi are preserved and produce the punctate vessels on the surface. Figure 19.10 Human papillomavirus (HPV)/cervical intraepithelial neoplasia 2 (CIN 2) presents as a white lesion with surface spicules."
        },
        {
            "id": "Gynecology_Novak_3017",
            "title": "Gynecology_Novak",
            "content": "Leukoplakia Translated literally, leukoplakia is white plaque (5). In colposcopic terminology, this plaque is white epithelium, visible before application of acetic acid. Leukoplakia is caused by a layer of keratin on the surface of the epithelium. Immature squamous epithelial cells have the potential to develop into keratin-producing cells or glycogen-producing cells. In the vagina and on the cervix, the normal differentiation is toward glycogen. Keratin production is abnormal in the cervicovaginal mucosa. Leukoplakia can be caused by HPV; keratinizing CIN; keratinizing carcinoma; chronic trauma from diaphragm, pessary, or tampon use; and radiotherapy."
        },
        {
            "id": "Gynecology_Novak_7573",
            "title": "Gynecology_Novak",
            "content": "As part of the clinical evaluation, a careful assessment of the extent of the lesion, including whether it is unifocal or multifocal, should be performed. The groin lymph nodes should be evaluated carefully, and a complete pelvic examination should be performed. A cytologic sample should be taken from the cervix, and colposcopy of the cervix and vagina should be performed because of the common association with other squamous intraepithelial or invasive neoplasms of the lower genital tract. Diagnosis Diagnosis requires a Keys punch biopsy or wedge biopsy, which can be obtained in the office using local anesthesia. The biopsy must include sufficient underlying dermis to assess for microinvasion. Physician delay is a common problem in the diagnosis of vulvar cancer, particularly if the lesion has a warty appearance. Any large or con\ufb02uent warty lesion requires biopsy before medical or ablative therapy is initiated. Routes of Spread Vulvar cancer spreads by the following routes: 1."
        },
        {
            "id": "Gynecology_Novak_3084",
            "title": "Gynecology_Novak",
            "content": "4. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665\u2013 669. 5. Hatch KD. Handbook of colposcopy: diagnosis and treatment of lower genital tract neoplasia and HPV infections. Boston, MA: Little Brown, 1989. 6. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci 1956;63:1245\u20131261. 7. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 1977;21:379\u2013390. 8. Beckmann AM, Myerson D, Daling JR, et al. Detection and localization of human papillomavirus DNA in human genital condylomas by in situ hybridization with biotinylated probes. J Med Virol 1985;16:265\u2013273. 9."
        }
    ],
    "scores": [
        0.03679212222270017,
        0.035143508158865425,
        0.03504076741641064,
        0.03432029673976703,
        0.034005709928735216,
        0.03369296467849316,
        0.03296253604816296,
        0.031882680053411765,
        0.031070403910089396,
        0.030433807934179647,
        0.02997050982296249,
        0.028717066931769585,
        0.0279448121346347,
        0.027296801179621438,
        0.025862610909339882,
        0.02457015219988572,
        0.023924741760944418,
        0.023431614024920312,
        0.0233963236155017,
        0.02316100989217671,
        0.021964213401686278,
        0.021845866816390027,
        0.02162497067545701,
        0.020775331517019498,
        0.02057873537011704,
        0.019670626373106674,
        0.019634014520630794,
        0.019501704586195136,
        0.019490478943912502,
        0.019040846061591222,
        0.01879008755883866,
        0.01860144416914812
    ]
}